AUG 01, 2016 12:21 PM PDT

$1.57 Million Grant to Combat Hospital-Acquired Infections

WRITTEN BY: Xuan Pham
Much like the bacteria that build plaque in your teeth, bacteria can colonize medical implants as slimy films that cause infections. Furthermore, these infections are often difficult to treat because the bacteria, especially those from hospitals, have become resistant to antibiotics. To reduce these types of infections, the National Institute of Health (NIH) recently awarded Clemson University scientists a $1.57 million grant aimed at a new detection technology.

Biofilm on a catheter | Image: wikimedia

Clemson’s team hope to tackle hospital-acquired infections through a dye-based sensor that’s sensitive to the acid levels on the surface of medical implants.

"What we're attempting to do is quite challenging," said Jeffrey Anker, Associate Professor of Chemistry at Clemson, and leader of the new project efforts. "We're trying to put a sensor on a plate that will be able to reside in a human body for a reasonable period of time in order to monitor changes in local acidity that will detect infection. Bacteria produce a lot of acids. A human's immune system also produces acids. So if low pH is detected on the surface of an implant, it will be reasonable to assume that the implant is infected. But our research will also delve more into these aspects to determine their validity."

In its planktonic form, the bacteria grow as single, independent cells, causing acute infections that can be treated with antibiotics. In its biofilm form, the bacteria exist as aggregated colonies that secrete a slimy film, which serves to protect them against the environment. More than 80% of infections are attributed to biofilms. In addition to growing on medical devices like dialysis catheters and contact lenses, biofilms can also dwell inside patients -- in the respiratory, gastrointestinal and urinary tracts, oral cavities, eyes, ears, wounds, heart and cervix. Because the slime protects them against antibiotics, some infections by biofilms are resistant to drugs and develop into a chronic state.

"Bacterial colonization of medical implants is a major cause of device failure and often requires device removal coupled with long-term antibiotic treatment," said Anker. "However, detection is challenging at early stages when the bacteria are localized to inaccessible regions of the implant. Our research will focus on developing sensors that will coat the implant. Then we'll use X-ray beams to scan the sensors, enabling us to detect and monitor the infection."
 

Most current technologies only detect bacterial infection when things get really bad for the patients. But when the infection is severe, antibiotics may not be enough for the drug-resistant biofilms. Even if the bacteria aren’t resistant, the slime surface enables some colonies to escape treatment and then sprouting new infections. “At this point, the implant typically needs to be tediously cleansed during a surgical procedure called debridement. If the biofilm isn't fully mature, this is sometimes effective. But if the biofilm has been long established, then debridement usually isn't good enough. The implant will then need to be removed and the remaining infection treated with antibiotics before a new implant is inserted,” explained Anker.

With the new research, the Clemson team hope to finally give doctors a leg-up on bacterial infections. Instead of playing catch-up with the bacteria, early detection could prompt faster and more effective treatments. And that’s important for everyone, as infections add a significant amount of burden on a health care system that’s already very stressed.
 

Additional source: Clemson University press release
About the Author
I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 22, 2022
Technology
Alzheimer's Diagnosis With a Single MRI Scan
JUN 22, 2022
Alzheimer's Diagnosis With a Single MRI Scan
Alzheimer’s, one of the more common forms of dementia, is a condition for which there is currently no cure. Accord ...
JUL 13, 2022
Clinical & Molecular DX
Nipah Virus: Moderna Invests in a Vaccine for the Virus that Fauci Calls a 'Pandemic Threat'
JUL 13, 2022
Nipah Virus: Moderna Invests in a Vaccine for the Virus that Fauci Calls a 'Pandemic Threat'
In Malaysia in the fall of 1998, a mystery ailment swept through the local pig-farming community, eventually leading to ...
JUL 19, 2022
Clinical & Molecular DX
As Rates of Thyroid Cancer Continue to Increase, Researchers Question Why
JUL 19, 2022
As Rates of Thyroid Cancer Continue to Increase, Researchers Question Why
Beginning in the early 1990’s, rates of thyroid cancer began to drastically increase. Though this trend has contin ...
JUL 26, 2022
Clinical & Molecular DX
Researchers Recognize New Complicating Factor in Organ Transplantation
JUL 26, 2022
Researchers Recognize New Complicating Factor in Organ Transplantation
Organ transplantation is a life-saving measure that is often a last resort to treat end-stage organ failure. Organ trans ...
AUG 02, 2022
Clinical & Molecular DX
CRISPR Technology Breaks New Ground with Edits to Gene that Regulates Cholesterol
AUG 02, 2022
CRISPR Technology Breaks New Ground with Edits to Gene that Regulates Cholesterol
In 2013, scientists described a method for editing the genome of eukaryotic cells (such at those found in humans) using ...
AUG 03, 2022
Neuroscience
Children Use Creativity in Response to Novel Tasks
AUG 03, 2022
Children Use Creativity in Response to Novel Tasks
A study by a research group at the Max Planck Institute examined how children employ creativity when faced with novel ta ...
Loading Comments...